Both Fasting and Glucose-Stimulated Proinsulin Levels Predict Hyperglycemia and Incident Type 2 Diabetes: A Population-Based Study of 9,396 Finnish Men
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Hyperproinsulinemia is an indicator of β-cell dysfunction, and fasting proinsulin levels are elevated in patients with hyperglycemia. It is not known whether proinsulin levels after a glucose load are better predictors of hyperglycemia and type 2 diabetes than fasting proinsulin. METHODS: Participants were 9,396 Finnish men (mean±SD, age 57.3±7.1 years, BMI 27.0±4.0 kg/m2) of the population-based METabolic Syndrome In Men Study who were non-diabetic at the recruitment, and who participated in a 6-year follow-up study. Proinsulin and insulin levels were measured in the fasting state and 30 and 120 min after an oral glucose load. Area under the curve (AUC) and proinsulin to insulin ratios were calculated. RESULTS: Fasting proinsulin, proinsulin at 30 min and proinsulin AUC during the first 30 min of an oral glucose tolerance test significantly predicted both the worsening of hyperglycemia and type 2 diabetes after adjustment for confounding factors. Further adjustment for insulin sensitivity (Matsuda index) or insulin secretion (Disposition index) weakened these associations. Insulin sensitivity had a major impact on these associations. CONCLUSION: Our results suggest that proinsulin in the fasting state and after an oral glucose load similarly predict the worsening of hyperglycemia and conversion to type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In healthy subjects, proinsulin accounts for up to 20% of the insulin levels in circulation, but in T2D this value can reach up to 50% and total proinsulin levels have shown to be higher in T2D patients than healthy controls, which suggests that dysfunctional processing and secretion of insulin by the remaining islet beta-cell population further contributes to the decreased insulin levels observed”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [103]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“Evaluation of insulin secretion (InsAUC0-30/GlucAUC0-30) and insulin sensitivity (Matsuda ISI) have been previously described [18,21].”
MethodStandards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s5 · Cited by 1,666
Leahy, J. L., Bonner-Weir, S., & Weir, G. C. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.442 · Cited by 357
Stančáková, A., Javorský, M., Kuulasmaa, T., Haffner, S. M., Kuusisto, J., & Laakso, M. (2009) · Diabetes · doi:10.2337/db08-1607 · Cited by 348 · cited 3×
“Evaluation of insulin secretion (InsAUC0-30/GlucAUC0-30) and insulin sensitivity (Matsuda ISI) have been previously described [18,21].”
MethodSelf-citationGlucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells
Schuit, F. C., In't Veld, P. A., & Pipeleers, D. G. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.3865 · Cited by 308 · cited 1×
“Prolonged exposure of β-cells to glucose results in abnormal proinsulin processing [7], which is related to the severity of hyperglycemia [3].”
BackgroundHuyghe, J. R., Jackson, A. U., Fogarty, M. P., Buchkovich, M. L., Stančáková, A., Stringham, H. M., Sim, X., Yang, L., Fuchsberger, C., Cederberg, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2507 · Cited by 282 · cited 1×
“Recent studies have shown that common and low-frequency gene variants regulate proinsulin levels [9], and that disruption of insulin receptor expression in beta-cells leads to poor proinsulin processing by altering the expression of carboxypeptidase E enzyme [10].”
BackgroundSelf-citationWard, W. K., LaCava, E. C., Paquette, T. L., Beard, J. C., Wallum, B. J., & Porte, D. (1987) · Diabetologia · doi:10.1007/bf00296991 · Cited by 275
Cited by
Reed, J., Bain, S., & Kanamarlapudi, V. (2021) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s319895 · Cited by 441
Thomas, M. K., Nikooienejad, A., Bray, R., Cui, X., Wilson, J., Duffin, K., Milicevic, Z., Haupt, A., & Robins, D. A. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa863 · Cited by 345
“Elevated proinsulin levels predict both worsening of hyperglycemia and progression of nondiabetic subjects to T2D in longitudinal cohorts (16).”
BackgroundBiomarkers for type 2 diabetes
Laakso, M. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.06.016 · Cited by 225
Self-citationThe Metabolic Syndrome in Men study: a resource for studies of metabolic and cardiovascular diseases
Laakso, M., Kuusisto, J., Stančáková, A., Kuulasmaa, T., Pajukanta, P., Lusis, A. J., Collins, F. S., Mohlke, K. L., & Boehnke, M. (2017) · Journal of Lipid Research · doi:10.1194/jlr.o072629 · Cited by 204
“Ketone bodies (13) Acetoacetate↑, -hydoxybutyrate↑ Acetoacetate↑ Non-cholesterol sterols (14) Desmosterol↑, campesterol↓, avenasterol↑ Desmosterol↑, campesterol↓, avenasterol↑ Glycerol, FAs (proton NMR) (15) Glycerol↑, free FAs↑, n-3 FAs↓, n-6 FAs↓, monounsaturated FAs↑, saturated n-7 and n-9 FAs↑ Glycerol↑, free FFA…”
BackgroundSelf-citationHyperinsulinemia: A cause of obesity?
Erion, K. A., & Corkey, B. E. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0261-z · Cited by 161
Cohort profile: the German Diabetes Study (GDS)
The GDS Group, Szendroedi, J., Saxena, A., Weber, K. S., Strassburger, K., Herder, C., Burkart, V., Nowotny, B., Icks, A., Kuss, O., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0374-9 · Cited by 151
“Defects in pancreatic beta-cell function are often preceded by insulin resistance [11–13] which is not only a feature of type 2 DM, but is also found in patients with type 1 DM [14, 15].”
BackgroundThe β Cell in Diabetes: Integrating Biomarkers With Functional Measures
Kahn, S. E., Chen, Y., Esser, N., Taylor, A. J., van Raalte, D. H., Zraika, S., & Verchere, C. B. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab021 · Cited by 80
“Thus, an alteration in the efficiency of proinsulin processing occurs before the development of frank hyperglycemia and could be a marker for the development of type 2 diabetes (417, 419, 420).”
Backgroundβ-Cell Failure or β-Cell Abuse?
Erion, K., & Corkey, B. E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00532 · Cited by 67
Increased β-Cell Workload Modulates Proinsulin-to-Insulin Ratio in Humans
Mezza, T., Ferraro, P. M., Sun, V. A., Moffa, S., CEFALO, C. M. A., Quero, G., Cinti, F., Sorice, G. P., Pontecorvi, A., Folli, F. B., et al. (2018) · Diabetes · doi:10.2337/db18-0279 · Cited by 65
“These data support our hypothesis that increased b-cell demand, rather than preexisting b-cell dysfunction per se, determines a rapid change in the proinsulin-to-insulin secretion ratio, in line with earlier studies showing that increased proinsulin levels, which are the consequence of impaired proinsulin conversion t…”
ResultRamos, J. S., Dalleck, L. C., Borrani, F., Mallard, A. R., Clark, B., Keating, S. E., Fassett, R. G., & Coombes, J. S. (2016) · Diabetologia · doi:10.1007/s00125-016-4064-7 · Cited by 67
“A recent study that followed 9396 non-type 2 diabetic individuals for 6 years showed fasting intact proinsulin concentration to be a predictor of both the worsening of hyperglycaemia and incidence of type 2 diabetes, with no difference in predictive capacity compared with intact proinsulin concentration level derived…”
BackgroundMethodInfluentialInside the Insulin Secretory Granule
Germanos, M., Gao, A., Taper, M., Yau, B., & Kebede, M. A. (2021) · Metabolites · doi:10.3390/metabo11080515 · Cited by 60
Kobiita, A., Godbersen, S., Araldi, E., Ghoshdastider, U., Schmid, M. W., Spinas, G. A., Moch, H., & Stoffel, M. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107846 · Cited by 58
“This observation is consistent with elevated proinsulin/insulin ratios in human T2D (Ward et al., 1987; Vangipurapu et al., 2015) and with studies demonstrating that proinsulin misfolding is an early feature in the progression of prediabetes (Liu et al.”
ResultBrusco, N., Sebastiani, G., Giuseppe, G. D., Licata, G., Grieco, G. E., Fignani, D., Nigi, L., Formichi, C., Aiello, E., Auddino, S., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05814-2 · Cited by 58
First-phase insulin secretion: can its evaluation direct therapeutic approaches?
Di Giuseppe, G., Ciccarelli, G., Soldovieri, L., Capece, U., Cefalo, C. M. A., Moffa, S., Nista, E. C., Brunetti, M., Cinti, F., Gasbarrini, A., et al. (2023) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2023.02.001 · Cited by 46
Schmid, V., Wagner, R. J., Sailer, C., Fritsche, L., Kantartzis, K., Peter, A., Heni, M., Häring, H., Stefan, N., & Fritsche, A. (2017) · Diabetologia · doi:10.1007/s00125-017-4407-z · Cited by 41
La Vignera, S., Cannarella, R., Galvano, F., Grillo, A., Aversa, A., Cimino, L., Magagnini, C. M., Mongioì, L. M., Condorelli, R. A., & Calogero, A. E. (2021) · Endocrine · doi:10.1007/s12020-020-02518-8 · Cited by 36
Then, C., Gar, C., Thorand, B., Huth, C., Then, H. L., Meisinger, C., Heier, M., Peters, A., Köenig, W., Rathmann, W., et al. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001425 · Cited by 20
“17 29 30 At a later stage, when β -cell failure and T2D become apparent, proinsulin levels will increase disproportionately, resulting in an elevated PIR.”
Intact Fasting Insulin Identifies Nonalcoholic Fatty Liver Disease in Patients Without Diabetes
Bril, F., McPhaul, M. J., Kalavalapalli, S., Lomonaco, R., Barb, D., Gray, M. E., Shiffman, D., Rowland, C. M., & Cusi, K. J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab417 · Cited by 17
Sims, E. K., Park, G. S. H., Mather, K. J., Mirmira, R. G., Liu, Z., & Gupta, S. K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197080 · Cited by 15
Russo, G. T., Giorda, C. B., Cercone, S., Cosmo, S. D., Nicolucci, A., Cucinotta, D., & the BetaDecline Study Group (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3016 · Cited by 13
“Still, the relationship between glucose control (HbA1c) and PI/I ratio is complex and bidirectional: on 1 side, high HbA1c levels may be a marker of glucotoxicity on beta cells,(2,3,48-50) whereas on the other, high PI levels may predict the worsening of hyperglycaemia and the conversion to T2DM in high‐risk individua…”
ResultPfützner, A., Schipper, D., Pansky, A., Kleinfeld, C., Roitzheim, B., & Tobiasch, E. (2017) · International Journal of Stem Cells · doi:10.15283/ijsc17033 · Cited by 15
“In addition, this diagnostic value of intact proinsulin when determined in fasting or postprandial blood samples for prediction of diabetes (19-22) but also of macrovascular events (23-25) has been confirmed in numerous well-documented prospective long-term epidemiological studies in small and…”
BackgroundChianelli, M., Armellini, M., Carpentieri, M. S., Coccaro, C., Cuttica, C. M., Fusco, A., Marucci, S., Nelva, A., Nizzoli, M., Ponziani, M. C., et al. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303282327240507184902 · Cited by 17
Metabolically healthy obesity: Is it really healthy for type 2 diabetes mellitus?
Wu, Q., Xia, M., & Gao, X. Y. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i2.70 · Cited by 14
Yang, Y., Wang, M., Tong, J., Dong, Z., Deng, M., Ren, X., Li, H., Yang, J., Meng, Z., Sun, J., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00549 · Cited by 12
Hjelmgren, O., Gummesson, A., Bergström, G. M. L., & Schmidt, C. (2020) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes19078 · Cited by 10
Emerging Biomarkers and Nanobiosensing Strategies in Diabetes
Baranwal, A., Bansal, V., & Shukla, R. (2025) · Biosensors · doi:10.3390/bios15100639 · Cited by 14
Proinsulin is sensitive to reflect glucose intolerance
Nakamura, A., Miyoshi, H., Ukawa, S., Nakamura, K., Nakagawa, T., Terauchi, Y., Tamakoshi, A., & Atsumi, T. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13106 · Cited by 11
Murai, N., Saito, N., Kodama, E., Iida, T., Mikura, K., Imai, H., Kaji, M., Hashizume, M., Kigawa, Y., Koizumi, G., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa066 · Cited by 10
“This is consistent with the results that P/I120 values were lower in IFG/IGT and diabetic participants than those in NGT [26].”
BackgroundResultRosenstock, J., Robins, D. A., Duffin, K. L., Wilson, J. M., Lin, Y., Banerjee, H., Eyde, S., KAZDA, C. M., Кониг, М., & Mather, K. J. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70022 · Cited by 13
“5 Conversely, reductions in proinsulin levels may indicate an improvement in pancreatic β -cell function.”
Li, M., Feng, D., Zhang, K., Gao, S., & Lu, J. (2016) · International Journal of Endocrinology · doi:10.1155/2016/4740678 · Cited by 7
“respect to proinsulin or PI/SI levels at 2 hours of an OGTT, we found the difference among the four groups was not so significant as their fasting levels, whichwas slightly consistent with the finding of a large population-based study in Finnish men [35].”
ResultHyperproinsulinemia in obesity and in type 2 diabetes and its relation to cardiovascular disease
Røder, M. E. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1331735 · Cited by 8
“Recently, in a large Finnish cohort study, elevated fasting PIM and AUC PIM during an OGTT was associated with worsening of hyperglycemia [42].”
BackgroundFisher, M. M., Smith, G. N., Potter, B. K., Arbuckle, T. E., Little, J., Weiler, H. A., Morisset, A., Lanphear, B. P., Braun, J. M., Kumarathasan, P., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf041 · Cited by 10
Fasting Proinsulin Independently Predicts Incident Type 2 Diabetes in the General Population
Sokooti, S., Dam, W., Szili‐Török, T., Gloerich, J., van Gool, A. J., Post, A., de Borst, M. H., Gansevoort, R. T., Heerspink, H. J. L., Dullaart, R. P. F., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12071131 · Cited by 6
Clinical and Laboratory Evaluation of a New Specific Point-of-Care Test for Intact Proinsulin
Pfützner, A., Pfützner, A. H., Kann, P. H., & Burgard, G. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816663745 · Cited by 6
Li, T., Quan, H., Zhang, H., Lin, L., Lü, L., Ou, Q., & Chen, K. (2020) · Aging · doi:10.18632/aging.103289 · Cited by 6
“In a most recent survey of 9396 Finnish men, both fasting and glucose-stimulated proinsulin levels are significantly associated with plasma glucose levels and insulin sensitivity [24].”
BackgroundParsons, V. A., Vadlamudi, S., Voos, K. M., Rohy, A. E., Moxley, A. H., Cannon, M. E., Rosen, J. D., Mills, C. A., Herring, L. E., Broadaway, K. A., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06391-w · Cited by 4
“In addition, increased secretion of the insulin precursor proinsulin and an altered ratio of proinsulin to insulin are associated with beta cell distress and are prognostic of type 2 diabetes [3–6].”
YURCHISHIN, M. L., Finn, A. R., Fowler, L. A., Vere-Whiting, S. L., & Gower, B. A. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag073 · Cited by 1
“The inclusion of 12-week fasting glucose as a covariate was due to differences in fasting glucose levels between diet groups at weeks 0 and 12, as it has been reported that elevated proinsulin levels are directly associated with hyperglycemia [21].”
Lin, L., Quan, H., Fang, T., Lu, L., Ou, Q., Zhang, H., Chen, K., & Zhou, Z. (2022) · Endokrynologia Polska · doi:10.5603/ep.a2022.0054 · Cited by 1
Positive association between proinsulin and fatty liver index in people with type 2 diabetes
Nakamura, A., Miya, A., Suzuki, Y., Nomoto, H., Kameda, H., Cho, K. Y., Nagai, S., & Atsumi, T. (2023) · Endocrine Journal · doi:10.1507/endocrj.ej23-0403 · Cited by 1
Obesity Influence on Insulin Activity and Resting Metabolic Rate in Type 2 Diabetes
Doros, R., Lixandru, D., Petcu, L. M., Picu, A. A., Mitu, M., Tudosoiu, J., & Ionescu-Tirgoviste, C. (2016) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.1515/rjdnmd-2016-0044 · Cited by 1
C-Peptide levels as a screening marker for initiating insulin therapy in type 2 diabetics.
Gul, S., Gul, A., Ali, A. F., Ullah, Z., & Ehsanullah, M. (2019) · The Professional Medical Journal · doi:10.29309/tpmj/2019.26.11.3093 · Cited by 1
Ogiso, K., Koriyama, N., Obo, T., Tokito, A., & Nishio, Y. (2020) · Diabetology International · doi:10.1007/s13340-020-00457-3 · Cited by 1
Кушнарёва, Н. Н., Zinych, О. В., Ковальчук, А., Прибила, О., & Шишкань-Шишова, Е. А. (2021) · World Science · doi:10.31435/rsglobal_ws/30032021/7507 · Cited by 1
Kern-Matschilles, S., Gar, C., Schilbach, K., Haschka, S. J., Rauch, B., Then, C., Seißler, J., Bidlingmaier, M., & Lechner, A. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1850-5392
Fasting proinsulin as a predictor of future glucose tolerance deterioration in Japanese adults
Kajihara, N., Tsuyama, T., Fukuda, K., Maekawa, A., Araki, E., Kubota, N., & Yamagata, K. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70461
“24, 26, 27 Type 2 diabetes has also been classi fi ed into eight clusters, one of which is characterized by elevated fasting proin-sulin levels.”
Jantz, J., Wiechel, P., Nixdorff, U., & Pfützner, A. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16100522
“Existing studies have used different protocols; therefore, the optimal time point and clinically validated cut-off for normoglycemic individuals remain to be established prospectively [36,42,43].”
Metadata
- Authors
- Vangipurapu, J., Stančáková, A., Kuulasmaa, T., Kuusisto, J., & Laakso, M.
- Affiliations
- University of Eastern Finland (FI)
- Corresponding author
- Laakso, Markku
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-04-08
- Volume
- 10
- Issue
- 4
- Pages
- e0124028
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4390238
- OpenAlex
- W1965469192
- Cited by
- 46
- References
- 39
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 5 · 2020: 8 · 2019: 4 · 2018: 4 · 2017: 5 · 2016: 5
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Itä-Suomen Yliopisto
- Academy of Finland
- Kuopion Yliopistollinen Sairaala
- Diabetestutkimussäätiö
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- proinsulin, hyperproinsulinemia, hyperglycemia, type 2 diabetes, oral glucose tolerance test, beta-cell dysfunction, insulin sensitivity, insulin secretion, proinsulin/insulin ratio, Finnish men
- MeSH terms
- Aged, Blood Glucose, Diabetes Mellitus, Diabetes Mellitus, Type 2, Fasting, Finland, Follow-Up Studies, Glucose Tolerance Test, Humans, Hyperglycemia, Insulin, Insulin Resistance, Male, Middle Aged, Prognosis, Proinsulin, Biomarkers, Area Under Curve
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.